A detailed history of Knollwood Investment Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Knollwood Investment Advisory, LLC holds 10,921 shares of LLY stock, worth $8.5 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
10,921
Previous 10,921 -0.0%
Holding current value
$8.5 Million
Previous $9.89 Billion 2.15%
% of portfolio
1.04%
Previous 1.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $1.59 Million - $1.99 Million
2,191 Added 25.1%
10,921 $9.89 Billion
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $4.58 Million - $5.41 Million
8,730 New
8,730 $5.09 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Knollwood Investment Advisory, LLC Portfolio

Follow Knollwood Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knollwood Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knollwood Investment Advisory, LLC with notifications on news.